Expanded Indication for DIACOMIT® (stiripentol)!

Approved for children 6 months and up!

DIACOMIT is the only FDA-approved antiseizure medication specifically for seizures associated with Dravet syndrome in children as young as 6 months. It is indicated for patients weighing 15 pounds or more and taking clobazam.

Prescribing Information

Save a copy of the full Prescribing Information.

You can also hover on the image below and use the menu to navigate through the document on your browser.

DIACOMIT_US_PI_2022

BBD-00238-062023

IMPORTANT SAFETY INFORMATION

WARNINGS & PRECAUTIONS

SleepinessDIACOMIT can cause sleepiness. Your healthcare provider should monitor you for sleepiness, particularly when DIACOMIT is used with other depressants or clobazam.

Decreased Appetite and WeightDIACOMIT can cause a loss in appetite and weight. Your healthcare provider should monitor your growth and weight carefully.

Read All